MRI特异性对比剂——普美显增强MRI在肝脏疾病诊断中的应用现状  

Current Status of MRI-specific Contrast Agent-Pramipexole Enhanced MRI in the Diagnosis of Liver Diseases

作　　者：陈好 古素娟 缪淑芳 CHEN Hao;GU Sujuan;MIAO Shufang(Department of Gastroenterology,Heyuan People's Hospital,Heyuan,Guangdong Province,517000 China)

机构地区：[1]广东省河源市人民医院消化内科,广东河源517000

出　　处：《世界复合医学》2023年第8期191-194,共4页World Journal of Complex Medicine

摘　　要：肝脏疾病是临床中比较常见的疾病类型,引起肝脏损伤的原因通常为病毒性感染,包含乙型、丙型肝炎、巨细胞病毒、腺病毒等。肝脏疾病的早期诊断极其重要,早诊断早治疗可帮助患者防止病情发展。影像学技术在肝脏疾病的诊断中意义重大,其中磁共振成像(magnetic resonance imaging, MRI)、电子计算机断层扫描技术(computed tomography, CT)这两种诊断技术最临床应用率较高,现阶段已成为肝脏疾病诊断的常用方法。磁共振存在良好的组织对比性,临床使用价值高。本文就MRI特异性对比剂——普美显增强MRI在肝脏疾病诊断中的应用现状展开综述。Liver disease is a relatively common type of disease in clinical practice,and the causes of liver injury are usually viral infections,including hepatitis B and C,cytomegalovirus,adenovirus,etc.Early diagnosis of liver diseases is extremely important,and early diagnosis and treatment can help patients prevent the development of the disease.Imaging techniques are of great significance in the diagnosis of liver diseases,among which magnetic resonance imaging(MRI)and computed tomography(CT)are two diagnostic techniques with high clinical application rate,and they have become the commonly used methods for the diagnosis of liver diseases at this stage.MRI has good tissue contrast and high clinical use value.In this paper,we review the current status of the application of MRI-specific contrast agent-Pramipexole enhanced MRI in the diagnosis of liver diseases.

关 键 词：MRI特异性对比剂——普美显 磁共振 肝脏疾病 准确性 

分 类 号：R575[医药卫生—消化系统]